calcitonin immunoassays due to the presence of heterophilic antibodies or macroaggregates (i.e.
23
falsely increased values or macrocalcitonin) (Alves et al. 2016) . Calcitonin can also remain 24 undetectable despite metastasis of rare tumor cells in thyroidectomized patients. In this context, 25 we designed a sensitive and specific technique to identify calcitonin-positive circulating tumor 26 cells (CTC) in medullary thyroid carcinoma. We demonstrate that calcitonin-positive CTCs are 27 present in the peripheral blood of medullary carcinoma patients following complete 28 thyroidectomy. Unexpectedly, the presence of CTCs could be identified up to 12 years after 29 surgery even in the absence of non-pathological levels of serum calcitonin.
30
Incidence of thyroid cancer significantly increased in the past several decades (Kuo et al. 
34
In these conditions, local or distant metastases are difficult to detect by radiographic imaging and 48 require additional and often expensive tests during follow-up. In this context, we investigated 49 another approach based on the identification of thyroid-specific circulating tumor cells (CTCs).
50
CTCs are cells that detach from the primary or metastatic tumor and intravasate into the blood 
89
Using these optimized experimental conditions, the presence of calcitonin-positive CTCs was 90 investigated in a series of subjects with medullary thyroid carcinoma. We selected 9 patients at 91 different TNM stages having undergone complete thyroidectomy and, except for #9, lacking any 92 evidence of other cancer (see Table 1 for clinical and pathological characteristics). The calcitonin 93 concentrations in the serum were above the basal level of the assay (i.e. 10 pg/ml) and ranged 94 from 48 to 10.600 pg/ml, further validating the diagnosis. Calcitonin-positive CTCs were 95 identified in all patients (from 1 to 7), except one (#1). Interestingly, the CTC counts did not 96 correlate with TNM classification as illustrated for example by patient #1 at pT3N1bM1 lacking 97 any detectable calcitonin-positive circulating cell while 5 CTCs were scored in subject #7 at 98 pT1N1bMx. Finally, the serum calcitonin concentrations did not correlate with CTC counts 99 (R 2 =0.11272, Figure 1E ). In particular, the calcitonin levels were low in patients #5, #7 and #8
100
(70, 48 and 82 pg/ml) while CTC counts were high (n=4, 5 and 7), respectively. hours. Despite these drawbacks, the ScreenCell device and calcitonin labeling methodology can,
120
as described, readily be set up in standard conditions of routine diagnosis.
121
Although the series of samples are limited, this report highlighted an unexpected and interesting 122 observation: relatively high CTC counts can be detected despite low calcitonin levels in the 123 serum of 3 patients (#5, #7 and #8). Since CTC numbers correlate with the probability of tumor 124 relapse, there is an intrinsic risk that prognosis of these subjects will worsen in a near future.
125
Careful follow up of these patients and further validation in larger cohorts will confirm this 126 observation. This is particularly important because follow-up periods in our series are longer in Blood from healthy subjects (#1, #2, #3 and #4) was analyzed by confocal microscopy after ScreenCell 44 filtration and SP17 labeling. 45 
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